Skip to podcast content

GLP-1 Hub Podcast

Not Losing Weight on a GLP-1? Questions Beyond Appetite Suppression

By the GLP-1 Hub editorial teamArticle published With Alex MufsonEpisode released May 11, 2026

Alex Mufson’s interview raises the difference between eating less and feeling well. Here is how to discuss limited response, symptoms and proposed testing with your care team.

Listen to this episode

The GLP-1 Hub Podcast

Open episode on Buzzsprout

If your appetite is strongly suppressed but you are not losing the weight you expected, eating even less is not a useful default plan. Bring the treatment timeline, actual eating pattern and any symptoms to your prescriber. A change in appetite and a satisfactory overall treatment response are different questions.

In her interview with Ana Reisdorf, therapist and Canary House founder Alex Mufson describes clients who feel they have followed every instruction yet remain disappointed or unwell. Her emphasis on listening to the full story is useful. Some of her proposed explanations and interventions, however, go beyond what the interview establishes as proven treatment for GLP-1 nonresponse.

Define what has and has not changed

“It is not working” can mean several things: little weight change, continuing food preoccupation, persistent fatigue or benefits that feel outweighed by symptoms. Those concerns may need different responses.

The NIDDK explains that results vary by medication and person, and that treatment decisions consider benefits, side effects, current conditions and other medicines. A social-media result cannot establish what response you should have or when a treatment needs changing.

Before your appointment, write down when treatment began, prescribed doses and changes, missed doses or access gaps, weight trends and what you are able to eat. Note improvements as well as problems. This helps your clinician assess the actual course rather than a label such as “nonresponder” applied after a difficult week.

Low intake deserves attention even without rapid weight loss

Mufson asks clients what eating looked like before medication and what changed during dose escalation. Skipping meals, relying on coffee or feeling unable to eat are details worth raising rather than hiding because the scale has not moved.

Those observations do not prove that the body is “refusing to release fat,” or that eating more will reliably reverse nonresponse. They identify a practical problem: you may be struggling to meet nutritional needs or participate comfortably in daily life.

Ask for a review of food and fluid intake, symptoms and medication tolerability. A registered dietitian can help make eating more manageable without treating every meal as a restriction challenge. Rob Hobson describes smaller, nourishing eating occasions that can be a starting point for that discussion.

Useful testing should answer a specific question

Mufson discusses standard blood work alongside additional microbiome and hormone-related testing. A reader should not infer that everyone with limited weight loss needs the same panel, or that an unusual result explains why a GLP-1 has not helped.

Ask the ordering clinician what condition they are investigating, how well the test answers that question and what would change in your care after either a normal or abnormal result. Ask about cost and whether a standard assessment can answer the same question.

A 2025 international consensus on microbiome testing found insufficient evidence to recommend its widespread routine use in clinical practice. Microbiome research is important, but a commercial report is not automatically a validated way to diagnose or treat GLP-1 nonresponse.

Similarly, a claim that a test reveals a “stress” or “survival” state needs a clear medical definition and evidence. It should not prevent investigation of symptoms through established clinical methods or imply that a normal routine test makes further medical care pointless.

Mental health support has value without a promised weight effect

Mufson describes people who care for others while neglecting their own needs, and she includes mental health professionals in her practice. If anxiety, distress around eating or exhaustion is affecting your life, those concerns deserve care in their own right.

That does not establish a personality type as the cause of nonresponse. Being a caregiver or having a trauma history is not proof that your brain is blocking weight loss. You should not have to accept that explanation to receive practical or emotional support.

The interview also discusses the difference between hunger and intrusive thoughts about food. A short description cannot determine the cause of either in an individual. Describe the frequency, distress and effect on daily life to an appropriate clinician rather than trying to diagnose a hormonal or psychiatric cause from one feeling.

Anecdotes about extra medicines are not a treatment protocol

Mufson describes supplement combinations, low-dose naltrexone and very low doses of tirzepatide in her approach. These are accounts of her practice and experience, not evidence from the interview that they reliably convert GLP-1 nonresponders into responders.

If any additional medicine is proposed, ask the licensed prescriber about the intended use, evidence in people with your problem, interactions, alternatives and monitoring. Do not copy doses from the conversation or change treatment independently. Make sure everyone involved knows your complete medication and supplement list.

Leave the review with a next step and a reassessment point

A useful visit should clarify what the care team thinks is happening, what they plan to investigate or change and when you should check back. Ask which symptoms need earlier contact and what happens if the next step does not help.

Limited response is not a moral failure, and persistence should not mean enduring an unworkable plan. Kelly Mooney’s slower journey offers perspective on function beyond the scale, while your own clinician can determine whether continuing, adjusting or changing treatment is appropriate for you.

The complete conversation

Prefer to read?

Explore the full episode transcript, with speaker labels and the original discussion.

Read the transcript